authorization – pharma.markets

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY

21/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.

11/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory […]

Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies

02/12/2020 MaP 0

• Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein • The spike protein is the target of many COVID-19 vaccines in […]

Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19

02/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted […]

New Emergency Use Authorization (EUA) for a Blood Purification System

10/04/2020 MaP 0

On April 9, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Terumo BCT Inc. and Marker Therapeutics AG […]

New Emergency Use Authorization (EUA) to Decontaminate Respirators

10/04/2020 MaP 0

On April 9, 2020, the U.S. Food and Drug Administration granted an emergency use authorization to STERIS Corporation for the STERIS V-PRO 1 Plus, maX […]